Trial Profile
Efficacy and Safety of Dexmedetomidine vs. Midazolam Sedation in Patients Undergoing Convex-probe Endobronchial Ultrasound: a Randomized Double Blind Trial
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 21 Feb 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Fentanyl (Primary) ; Midazolam
- Indications Sedation
- Focus Therapeutic Use
- 16 Feb 2017 Status changed from active, no longer recruiting to completed.
- 10 Feb 2017 Planned End Date changed from 1 Feb 2017 to 11 Feb 2017.
- 10 Feb 2017 Planned primary completion date changed from 1 Jan 2017 to 11 Feb 2017.